To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Aspens results for the half-year ended 31 December 2018 and Interim results presentation

Release Date: 04/03/2019 13:00
Code(s): APN     PDF:  
 
Wrap Text
Aspen’s results for the half-year ended 31 December 2018 and Interim results presentation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Company”)


ASPEN’S RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2018 AND INTERIM RESULTS PRESENTATION

Shareholders are advised that Aspen intends releasing its results for the half-year ended 31 December 2018
after market close on Thursday, 7 March 2019 on SENS. This announcement will be followed by a
presentation to members of the investment community on Friday, 8 March 2019 in Cape Town.

All interested stakeholders are invited to access the presentation, scheduled for 08h30 (CAT) on
8 March 2019, via webcast. Participation will be live via webcast and those interested are requested to access
the link below by no later than 08h15 (CAT) in order to register for the webcast.

Webcast registration and access: http://presentations.corpcam.com/Registration.aspx?id=Aspen09032018

The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com)
in the Investor Information section shortly before the commencement of the presentation on
8 March 2019.

A playback of the webcast will be made available on the Aspen website approximately
2 hours after the presentation.



Durban
4 March 2019

Sponsor:
Investec Bank Limited

Date: 04/03/2019 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story